Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) EBITDA (2016 - 2025)

Bio-Techne (TECH) has 17 years of EBITDA data on record, last reported at $40.1 million in Q4 2025.

  • For Q4 2025, EBITDA rose 329.51% year-over-year to $40.1 million; the TTM value through Dec 2025 reached $104.4 million, down 23.31%, while the annual FY2025 figure was $91.8 million, 41.08% down from the prior year.
  • EBITDA reached $40.1 million in Q4 2025 per TECH's latest filing, up from $33.7 million in the prior quarter.
  • Across five years, EBITDA topped out at $84.9 million in Q4 2021 and bottomed at $4.5 million in Q2 2025.
  • Average EBITDA over 5 years is $46.9 million, with a median of $41.6 million recorded in 2022.
  • The widest YoY moves for EBITDA: up 329.51% in 2025, down 88.04% in 2025.
  • A 5-year view of EBITDA shows it stood at $84.9 million in 2021, then dropped by 21.46% to $66.7 million in 2022, then crashed by 37.29% to $41.8 million in 2023, then crashed by 77.7% to $9.3 million in 2024, then soared by 329.51% to $40.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $40.1 million in Q4 2025, $33.7 million in Q3 2025, and $4.5 million in Q2 2025.